골 재생을 위한 생체재료와 미래. (Korean)

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): 박형열; 김상일; 김영훈
  • Source:
    Journal of the Korean Orthopaedic Association / Daehan Jeonghyeong Oe'gwa Haghoeji; Dec2022, Vol. 57 Issue 6, p447-456, 10p
  • Additional Information
    • Alternate Title:
      Biomaterials and Futures for Bone Regeneration. (English)
    • Abstract:
      Bone regeneration of bone defects caused by trauma, infection, tumors, or genetic disorders is a clinical challenge that usually necessitates bone-grafting materials. Autologous bone grafts are still considered the clinical “gold standard” and the most effective for bone regeneration. On the other hand, autografts have limitations, including limited graft supply, secondary injury, chronic pain, and infection. The development of biomaterials could provide environments to facilitate bone regeneration. By combining scaffolds, stem cells, and growth factors, biomaterials play a successful role as biological substitutes to restore the functions of injured bone. On the other hand, some unsolved problems remain. The development of biomaterials through artificial intelligence and personalized medicine, such as patient-derived stem cells and three-dimensional printing techniques, could be alternatives in the future. This review summarizes the latest research and futures in biomaterials for clinical applications. [ABSTRACT FROM AUTHOR]
    • Abstract:
      Copyright of Journal of the Korean Orthopaedic Association / Daehan Jeonghyeong Oe'gwa Haghoeji is the property of Korean Orthopaedic Association and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)